| ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome A Goyal, D O'Leary, B Dabaja, WK Weng, J Zain, C Cutler, J Guitart, ... Transplantation and Cellular Therapy, 2024 | | 2024 |
| Structural white matter abnormalities in Schizophrenia and associations with neurocognitive performance and symptom severity AG Male, E Goudzwaard, S Nakahara, JA Turner, VD Calhoun, ... Psychiatry Research: Neuroimaging 342, 111843, 2024 | | 2024 |
| The Prevalence and Impact of Pre-Transplant Frailty and Mental Distress on Outcomes in Hematopoietic Cell Transplantation S Singh, Q Cao, C Demorest, F He, SG Holtan, JE Maakaron, D O'Leary, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis A Goyal, D O’Leary, F Foss Bone marrow transplantation 59 (1), 41-51, 2024 | 8 | 2024 |
| Phase I Study of FT538+ Daratumumab for Treatment of r/r AML JE Maakaron, C Seichter, R Wangen, A Hoeschen, DK Krishnadas, ... Blood 142, 4842, 2023 | 2 | 2023 |
| Simvastatin with Intrathecal Dexamethasone Reduces Neurotoxicity in Adults Receiving Chimeric Antigen Receptor (CAR) T-Cells Treatment N Sumransub, C Seichter, K Kent, R Shanley, M Hu, D O'Leary, ... Blood 142, 3493, 2023 | | 2023 |
| Auditory oddball hypoactivation in schizophrenia S Nakahara, AG Male, JA Turner, VD Calhoun, KO Lim, BA Mueller, ... Psychiatry Research: Neuroimaging 335, 111710, 2023 | | 2023 |
| Phase II study of myeloablative 7-8/8-matched allotransplantation with post-transplantation cyclophosphamide, tacrolimus, and mycophenolate mofetil N El Jurdi, A Hoover, D O'Leary, Q Cao, A Gupta, C Ebens, JE Maakaron, ... Transplantation and Cellular Therapy 29 (9), 576. e1-576. e5, 2023 | 2 | 2023 |
| Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil. NE Jurdi, A Hoover, D O'Leary, Q Cao, A Gupta, C Ebens, JE Maakaron, ... Transplantation and Cellular Therapy 29 (9), 576. e1-576. e5, 2023 | 6 | 2023 |
| Acute kidney injury in vancomycin-induced drug reaction with eosinophilia and systemic symptoms: A case-control study N Milani-Nejad, J Trinidad, BH Kaffenberger Journal of the American Academy of Dermatology 88 (5), 1121-1123, 2023 | 3 | 2023 |
| Negative Affect, Affect Regulation, and Food Choice: A Value-Based Decision-Making Analysis D O’Leary, A Smith, E Salehi, JJ Gross Social Psychological and Personality Science 14 (3), 295-304, 2023 | 1 | 2023 |
| A method for estimating and characterizing explicitly nonlinear dynamic functional network connectivity in resting-state fMRI data SM Motlaghian, V Vahidi, B Baker, A Belger, JR Bustillo, A Faghiri, ... Journal of neuroscience methods 389, 109794, 2023 | 9 | 2023 |
| Recreational Marijuana use, adolescent cognitive development, and schizophrenia susceptibility BC Ho, AB Barry, JA Koeppel, J Macleod, A Boyd, A David, DS O’Leary Biological psychiatry global open science 3 (2), 222-232, 2023 | 9 | 2023 |
| Phase II study of myeloablative 8/8-or 7/8-matched allotransplantation with post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil: marked reduction in GVHD … N El Jurdi, A Hoover, D O’Leary, Q Cao, A Gupta, C Ebens, J Maakaron, ... medRxiv, 2023 | 4 | 2023 |
| Five negative symptom domains are differentially associated with resting state amplitude of low frequency fluctuations in Schizophrenia E Cheon, AG Male, B Gao, BM Adhikari, JT Edmond, SM Hare, A Belger, ... Psychiatry Research: Neuroimaging 329, 111597, 2023 | 3 | 2023 |
| Financial constraint and perceptions of COVID-19 JS Trueblood, AB Sussman, D O’Leary, WR Holmes Scientific Reports 13 (1), 3432, 2023 | 9 | 2023 |
| Cryopreservation for Allogeneic Hematopoetic Stem Cell Transplants Is Non-Inferior to Fresh Graft Products D O'Leary, A Goyal, Q Cao, JE Maakaron, SG Holtan, BC Betts, N El Jurdi, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| Allogeneic Hematopoietic Stem Cell Transplantation (HCT) Using Reduced Intensity Conditioning with Cyclophosphamide/Fludarabine/Total Body Irradiation (TBI) with Tacrolimus … A Firoozmand, DO Leary, Q Cao, AO Gupta, CL Ebens, JE Maakaron, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| Phase II study of myeloablative 8/8-or 7/8-matched allotransplantation with post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil: marked reduction in GVHD … SG Holtan, A Hoover, D O'Leary, Q Cao, AO Gupta, CL Ebens, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | 1 | 2023 |
| A Practical Review of the Presentation, Diagnosis, and Management of Cutaneous B-Cell Lymphomas N Goyal, D O’Leary, JB Carter, N Comfere, O Sokumbi, A Goyal Dermatologic Clinics 41 (1), 187-208, 2023 | 1 | 2023 |
